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Summary
Human embryonic stem (hES) cells show an atypical cell-
cycle regulation characterized by a high proliferation rate
and a short G1 phase [1,2]. In fact, a shortened G1 phase
might protect ES cells from external signals inducing differ-
entiation, as shown for certain stem cells [3]. It has been sug-
gested that self-renewal and pluripotency are intimately
linked to cell-cycle regulation in ES cells [4–6], although little
is known about the overall importance of the cell-cycle
machinery in maintaining ES cell identity. An appealing
model to address whether the acquisition of stem cell prop-
erties is linked to cell-cycle regulation emerged with the
ability to generate induced pluripotent stem (iPS) cells by
expression of defined transcription factors [7–11]. Here, we
show that the characteristic cell-cycle signature of hES cells
is acquired as an early event in cell reprogramming. We
demonstrate that induction of cell proliferation increases
reprogramming efficiency, whereas cell-cycle arrest inhibits
successful reprogramming. Furthermore, we show that
cell-cycle arrest is sufficient to drive hES cells toward irre-
versible differentiation. Our results establish a link that
intertwines the mechanisms of cell-cycle control with the
mechanisms underlying the acquisition and maintenance
of ES cell identity.
Results
Acquisition of a High Proliferation Rate Is an Early Event
in Cell Reprogramming
Human induced pluripotent stem (hiPS) cells are molecularly
and functionally similar to human embryonic stem (hES) cells
in terms of pluripotent gene expression and the ability to
support differentiation into the three embryonic germ layers
[7–11]. In agreement, we have observed that the characteristic
cell-cycle structure of hES cells, comprised of a large number
of cells in S phase and an abbreviated G1 phase [1, 2], is also
acquired in established hiPS cell lines (see Figure S1 and
Supplemental Results available online). Thus, this led us to
investigate whether the acquisition of this profile is an early
step in the process of reprogramming. To this end, we used
keratinocytes, a cell source with high reprogramming effi-
ciency, where nascent iPS cell colonies arise between*Correspondence: belmonte@salk.edu10 and 14 days during the reprogramming process [12].
Therefore, we analyzed the cell-cycle profile of emerging iPS
cell colonies as identified by the stem cell surface markers
Tra-1-81 and Tra-1-60, 12 days after the expression of OCT4,
SOX2, KLF4, and cMYC (OSKC) [13] (Figure 1A). The Tra-1-60+
and Tra-1-81+ populations of cells displayed a cell-cycle
profile similar to that observed in hES cells (H9 cell line), in
contrast to the Tra-1-602 and Tra-1-812 populations (Fig-
ure 1A). Next, we also analyzed the level of proliferation, by
measuring the percentage of bromodeoxyuridine (BrdU) incor-
poration in emerging iPS cell colonies that express the stem
cell marker Nanog. We determined that the percentage of
BrdU+ cells in hES and the nascent Nanog+ iPS cell colonies
was similar and was in contrast to the reduced levels of
BrdU+ cells observed in the somatic cell of origin (Figure 1B).
To further evaluate these findings, we developed a cellular
assay to identify early hiPS cell colonies based on the expres-
sion of a green fluorescent protein (GFP) gene driven by the
endogenous OCT4 promoter. It has been shown that reactiva-
tion of endogenous pluripotent gene expression is a necessary
and early event for successful reprogramming [14]. Therefore,
we differentiated a knockin OCT4GFP humanH1 ES cell line [15]
into a fibroblast-like population of cells (dFib-OCT4GFP; Fig-
ure S2). Transduction of dFib-OCT4GFP cells with OSKC reac-
tivated the expression of the endogenous OCT4 locus, which
correlated with the appearance of GFP (Figure S2B). More-
over, we determined that emerging GFP+ hiPS cell colonies
are still not transcriptionally identical to hES cells, in contrast
to established GFP+ hiPS cell lines, thus suggesting that this
population represents iPS cells that are not yet fully mature
(Figure S2C). In experiments to assess proliferation, we
observed a comparable percentage of BrdU+ cells in hES cells
and early GFP+ hiPS cells that was significantly higher than the
percentage observed in the parental population (Figure 1C).
Moreover, we were able to detect highly proliferative GFP+
colonies as early as 10 days after transduction with OSKC (Fig-
ure 1D). Finally, we analyzed the percentage of cells positive
for phosphohistone H3, a well-defined mitotic marker, to
further assess the acquisition of proliferative abilities in
emerging hiPS cell colonies. We observed that GFP+ colonies
derived fromdFib-OCT4GFP cells, aswell as Tra-1-60+ colonies
derived from keratinocytes, showed a similar percentage of
phosphohistone H3+ cells compared to hES cells, which was
significantly higher than the percentages found in the starting
cell populations (Figures 1E and 1F). Collectively, these data
strongly suggest that the characteristic proliferative abilities
of hES cells are acquired as an early event in the generation
of hiPS cells.
Induction of Cell Proliferation Promotes Formation
of hiPS Cells, Whereas Cell-Cycle Arrest Inhibits
Cell Reprogramming
It has been reported that the expression of OSKC triggers
a senescence response and induces a G1 cell-cycle arrest
[16]. Cell-cycle progression through G1 to S phase requires
the stepwise phosphorylation and functional inactivation of
retinoblastoma (pRb), which regulates cell-cycle progression
through the binding to and inhibition of E2F transcription
Figure 1. The Characteristic Cell-Cycle Signature of Human Embryonic
Stem Cells Is Acquired Early in Reprogramming
(A) Cell-cycle distribution analyzed by 5-ethynyl-20-deoxyuridine (EdU)
incorporation of the Tra-1-60- and Tra-1-81-positive and -negative popula-
tions of cells obtained 12 days after the first infection (OCT4, SOX2, KLF4,
and cMYC; OSKC) of keratinocytes (Ke). H9 cells were included as a positive
control for staining. Two independent experiments were performed, and
5000 cells are represented in each dot plot.
(B) Percentage of Nanog+/BrdU+ cells in H9 and nascent human induced
pluripotent stem (hiPS) cells compared to thepercentageofBrdU+ cells in ker-
atinocytes (Ke). Aminimumof tenNanog+colonieswereevaluated in two inde-
pendent experiments. Cells were incubated with 10 mM BrdU for 30 min.
Results in (B), (C), (E), and (F) are shown as average6 standard deviation (SD).
(C) Quantification of the percentage of BrdU+ cells in early emerging hiPS
colonies obtained 14 days after the first infection of dFib-Oct4GFP cells
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46factors [17]. This phosphorylation is mediated by cyclin-
dependent kinases (CDKs), which require for their activation
the binding of cyclins (Cyc) [18]. Therefore, formation of the
CycD-CDK4/6 and CycE/A-CDK2 complexes allows progres-
sion of cells into S phase. Conversely, cell-cycle arrest is
mediated through the expression of CIP/KIP (p21, p57, and
p27) and INK4 (p15, p16, p18, and p14) family members of
CDK inhibitors (CKIs) [17–20]. We tested whether overcoming
the OSKC-induced cell-cycle arrest in order to establish the
hES cell-cycle structure in hiPS cells was an important event
during the acquisition of pluripotency. Thus, we investigated
whether modulation in the expression of proteins involved in
the control of the G1-to-S phase transition, and hence the
proliferation status, would affect the efficiency of cell reprog-
ramming. To this end, we designed a panel of lentiviruses en-
coding short hairpin RNAs against pRb, CDK2/4, CycE1, and
CycD1/D2 (Figure S3A) and retroviruses encoding different
cell-cycle proteins (p15, p16, p21, CycD1/D2, CDK1/2/4, and
CycE2) and coinfected them with OSKC in keratinocytes.
Downregulation of pRb induced an average 3-fold increase
in the efficiency of reprogramming (Figure 2A). Interestingly,
we observed that no colonies arose from keratinocytes when
CycE1 (a CDK2 activator) or CycD2 (a CDK4 activator) was
downregulated (Figure 2A), whereas no changes in reprogram-
ming efficiency were detected following CDK2, CDK4, or
CycD1 downregulation (Figure 2A). We also found that ectopic
expression of the cell-cycle arrest mediators p15, p16, or p21
resulted in almost no hiPS cell colony formation (Figure 2B).
Moreover, we observed that expression of CycD1, CycD2,
and CycE2, but not CDK1, CDK2, or CDK4, increased reprog-
ramming efficiency up to more than 2-fold compared to
controls (Figure 2C). Similar results were obtained with either
IMR90 or BJ fibroblasts (data not shown).
Next, we hypothesized that the expression of a cyclin
together with its CDK catalytic partner, rather than its expres-
sion alone, might have a more profound effect on reprogram-
ming efficiency. Indeed, we observed a dramatic increase in
reprogramming efficiency, up to 10-fold, by coexpressing
CycD1/CDK4 in BJ fibroblasts, a cell type that typically
reprograms less efficiently than keratinocytes (Figure 2D).
Importantly, we observed that changes in cell proliferation
correlated perfectly with changes in reprogramming efficiency
(Figures 2E–2G). Moreover, we further used cumulative BrdU
labeling, which provides information about the rate of S phase
entry and the length of the cell cycle [21], to determine that
either overexpression of p16, p15, or p21 or downregulation
of CycD2 or CycE1 resulted in a permanent cell-cycle arrest
in the population of cells subjected to reprogramming.
However, overexpression of CycD1, CycE2, or CDK4/CycD1
or downregulation of pRb resulted in a constant increased
rate of cells entering into S phase over the time of the analysiswith OSKC. H9 cells as well as the original dFib-Oct4GFP population of cells
were included for comparison. A minimum of ten GFP+ colonies were
evaluated in two independent experiments. Cells were incubated with
10 mM BrdU for 30 min.
(D) BrdU immunofluorescence in hiPS cells obtained 10 days after the first
infection of dFib-Oct4GFP cells with OSKC. A representative example is
shown.
(E and F) Quantification of the percentage of phosphohistone H3+ cells in
hiPS colonies obtained 12 or 14 days after the first infection of keratinocytes
(Ke, E) or dFib-Oct4GFP cells (F), respectively, with OSKC. H9 cells as well as
the original population of cells were included for comparison. A minimum of
ten GFP+ (E) or Tra-1-60+ (F) colonies were evaluated in two independent
experiments.
Figure 2. Reprogramming Efficiency Is Influenced by Modulations in the Expression of Proteins Involved in the G1-to-S Phase Transition
(A–D) Human cultures of keratinocytes (A–C) or BJ fibroblasts (D) were infected with retroviruses encoding the four reprogramming factors (OCT4,
SOX2, KLF4, and cMYC), and either lentiviruses encoding short hairpin RNAs (shRNAs) against the indicated proteins (A) or retroviruses encoding the indi-
cated proteins (B–D). Relative reprogramming efficiencies normalized to the efficiency observed in pMX-GFP- or pLVTHM-infected keratinocytes respec-
tively are shown with the fold changes indicated. Uninfected cells were used as a negative control for all experiments. Error bars represent the SD.
(E–G)PercentageofBrdU+cells inkeratinocytes (EandF)orBJfibroblasts (G)4daysafter infectionwithOSKCpluseither retrovirusesexpressing thenotedproteins
or lentiviruses expressing the indicated shRNAs. Note the different percentage of BrdU+ cells between the experimental controls, pMX- or pLVTHM-infected ker-
atinocytes (E and F, respectively), due to the different viral deliverymethod (retrovirus versus lentivirus) used. Two independent experiments were performed, and
the results arepresentedasaverages6SDof at least 300cells scored in threedifferent fields inbothexperiments.Cellswere incubatedwith 10mMBrdU for 60min.
(H)Upperpanel:numberofGFP+coloniesper105cellsseededfollowing infectionofdFib-Oct4GFPcellswith therespective retroviruses.Twoindependentexperiments
wereperformed,and the results arepresentedas theaverage6SDof twobiological replicatesperexperiment. Lowerpanels:morphological aspect andGFPexpres-
sion or Nanog staining of colonies obtained from the different conditions 8 days (lower left) or 16 days (lower right) after first infection. Scale bars represent 100 mm.
n indicates number of independent experiments. Sc indicates scrambled shRNA.
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Figure 3. Cell-Cycle Arrest in Human Embryonic Stem Cells Induces Differentiation
(A) Western blot analysis of GFP-, p15-, p16-, and p21-inducible H9 cell line protein extracts 24 hr after treatment with 200 ng/ml doxycycline.
(B) Cumulative BrdU labeling curves for the GFP-, p15-, p16-, and p21-inducible H9 cell lines. After 24 hr of culture with or without doxycycline, fresh BrdU
was added to the medium every 2 hr, and the BrdU labeling index was analyzed at different time points as indicated. The BrdU labeling index indicates the
proportion of DAPI-stained nuclei that were positive for BrdU incorporation. Each time point represents the average and standard deviation of triplicate
counts of at least 500 nuclei in different fields in two biological replicates. The upper dashed line represents the maximum labeling index, which was similar
independent of doxycycline treatment. The time necessary to reach the maximum labeling index corresponds to the total cell-cycle length minus the length
of the S phase (TG2+M+G1) [21].
Current Biology Vol 21 No 1
48
High Proliferation Rate and ES/iPS Identity
49compared to control cells (Figure S3B). In summary, our
results suggest that alleviation of the cell-cycle arrest induced
by OSKC, by promoting S phase entry, increases the efficiency
of cell reprogramming, whereas a further induction of cell-
cycle arrest has the opposite effect (Figures 2E–2G).
We next examinedwhether the observed increase in reprog-
ramming efficiency following induced proliferation was due to
an acceleration in the rate of reprogramming or to an increase
in the number of cells amenable to being reprogrammed. To
this end, we infected dFib-OCT4GFP cells with OSKC alone,
OSKC+CycD1, or OSKC+CDK4/CycD1. The appearance of
the first GFP+ colonies following OSKC expression were
detected as early as 8 days after infection (Figure 2H). Surpris-
ingly, we did not observe differences in the rate of cell reprog-
ramming upon increasing cell proliferation, as mediated by
CycD1 or CycD1/CDK4, because all conditions showed
GFP+ colonies by day 8 (Figure 2H). However, in agreement
with our previous findings, we observed many more colonies
when CycD1 or CycD1/CDK4 was overexpressed (Figure 2H).
Collectively, these data demonstrate that an increase in the
proliferation rate induces a burst in the number of cells
amenable to being reprogrammed, rather than modifying the
kinetics of the reprogramming process.
Cell-Cycle Arrest Is Sufficient to Drive hES Cells toward
Irreversible Differentiation
We have shown that acquisition of self-renewal and pluripo-
tency during cell reprogramming is associated with the
successful overcoming of the cell-cycle arrest mediated by
OSKC and the establishment of the ES cell-cycle structure.
Next, we investigated whether self-renewal and pluripotency
are dependent on the atypical mode of cell-cycle regulation
in hES cells. We generated H9 cell lines harboring doxycycline
(dox)-inducible expression constructs for the cell-cycle arrest
inducers p15, p16, and p21 to determine whether overexpres-
sion of these proteins in hES cells poises them for differentia-
tion by promoting changes in the cell-cycle structure. We
detected a significant increase in the percentage of hES cells
in G1 phase as early as 24 hr after induction of p15, p16, or
p21 expression, with p21 showing the most dramatic effect
(Figures 3A and 3B and data not shown). The accumulation
of cells in G1 phasemight indicate that a subpopulation of cells
is arresting in G1, but it could also suggest that cells are under-
going a lengthening of G1 phase. To distinguish between these
two possibilities, we subjected our inducible hES cell lines to
cumulative BrdU labeling. Via this approach, we were able
to establish the time spent in the G2, M, and G1 phases
(TG2+M+G1) (see Supplemental Experimental Procedures for
details).Weobserved that induction of p21 resulted in aperma-
nent cell-cycle arrest (Figure 3B), whereas induction of p15 or
p16 resulted in an increased TG2+M+G1 ofw40% (15.52 hr [dox]
versus 11.03 hr [no dox]) or w30% (12.9 hr [dox] versus
9.94 hr [no dox]), respectively. Importantly, we did not detect
significant changes in TG2+M+G1 when GFP was induced
(TG2+M+G1 = 8.71 hr [dox] versus 9.27 hr [no dox]) (Figure 3B).
Next, we assessed the effects of p15-, p16-, or p21-mediated(C) Cell morphology of the same cell lines in the absence of doxycycline (day
embryonic stem (hES) cell-like colonies observed in the case of p15- and p16-
(D) Immunofluorescence analysis of BrdU and Oct4 in the p15-, p16-, and p21-in
nies are outlined with dashed lines. Scale bar represents 100 mm. Cells were in
(E) Western blot analysis of the indicated proteins in the GFP- and p21-expres
(F) Immunofluorescence analysis of differentiationmarkers for themesodermal
AFP, albumin, and FoxA2) germ layers in the p15-, p16-, and p21-inducible H9 c
represents 100 mm.cell-cycle changes on hES self-renewal and pluripotency. Pro-
longed induction of p21 resulted in massive cell differentiation
into nonproliferative cells following 10 days of doxycycline
treatment (Figures 3C–3F). In contrast, the expression of p15
or p16 resulted in an intermediate phenotype in which highly
proliferative hES cell-like colonies were detected but were
surrounded by differentiated nonproliferative cells (Figures
3C and 3D). We then performed gene expression and protein
analysis of pluripotency and differentiation markers in the
inducible H9 cell lines maintained in normal growth medium
or following 10 days of continuous doxycycline treatment
(Figures 3D–3F and data not shown). We detected OCT4
expression after overexpression of p15 or p16 in the areas
that morphologically resembled hES cells, but not in their
surrounding differentiated populations (Figure 3D). However,
OCT4 expression was lost after continuous p21-induced cell-
cycle arrest in hES cells (Figures 3D and 3E). Furthermore, in
hES cells where p15, p16, or p21 was induced, we detected
elevated expression levels of several differentiation markers,
which was not observed in the control GFP line or in the
same lines not treated with doxycycline (Figure 3F and data
not shown).
Next, we investigated whether the cell-cycle-induced differ-
entiation in hES cells is reversible. We also evaluated the
minimum duration of cell-cycle inhibitor expression required
to trigger differentiation. To this end, we analyzed the mor-
phology as well as the expression of differentiation markers
in cells where p21 expression was induced by adding doxycy-
cline to the medium for the indicated number of days followed
by its withdrawal at each indicated time point and culturing for
a total of 10 days (Figure 4A). Interestingly, we observed that
only 1 day of p21 induction resulted in cultures where morpho-
logically hES-like cells were surrounded by differentiated cells
(Figures 4B and 4C). We also determined that 3 days of contin-
uous p21 induction was enough to trigger massive differentia-
tion, and that withdrawal of doxycycline was not sufficient
to rescue the differentiation phenotype (Figures 4B–4D).
Consequently, continuous induction of p21 expression for
more than 3 days resulted in stronger expression of several
differentiation markers (Figure 4D). In contrast, we did not
observe any morphological changes and/or expression of
differentiation markers after inducing expression of GFP
(data not shown). Taken together, these data suggest that
differentiation induced by cell-cycle arrest in hES cells is an
irreversible process.
Discussion
Our data establish an essential role for cell proliferation in both
cell reprogramming and the maintenance of self-renewal and
pluripotency in hES cells. We showed that alteration in the
rate of hES cell proliferation leads to a compromise in themain-
tenance of self-renewal and pluripotency. In fact, we observed
that expressionof p15orp16 in hEScells induces a lengthening
of the average time spent in the G2, M, and G1 phases that
correlates with an increased propensity to differentiate. The0) or 2, 6, and 10 days after p15, p16, or p21 induction. The small human
expressing lines are outlined by dashed lines. Scale bar represents 100 mm.
ducible H9 cell lines after 10 days of induction with doxycycline. Oct4+ colo-
cubated with 10 mM BrdU for 30 min.
sing H9 cell lines with or without doxycycline induction for 10 days.
(SMA), trophectodermal (Cdx2), ectodermal (Tuj1), and endodermal (GATA4,
ell lines following 10 days of induction with 200 ng/ml doxycycline. Scale bar
Figure 4. Differentiation Mediated by p21 Expression in hES Cells Is an Irreversible Process
(A) Schematic representation of the experiment performed. Briefly, p21 expression was induced and maintained as indicated by adding doxycycline to the
medium for the indicated number of days, followed by its withdrawal at each indicated time point. All cells were analyzed following a total of 10 days in
culture.
(B) Cell morphology of the GFP- and p21-inducible cell lines maintained for 10 days in the indicated conditions. The small hES cell-like colonies observed
after a single day of p21 induction are outlined by dashed lines. Scale bars represent 100 mm.
(C) Immunofluorescence analysis of the differentiation markers for the mesodermal (SMA), trophectodermal (Cdx2), ectodermal (Tuj1), and endodermal
(AFP, albumin, and FoxA2) germ layers in the p21-inducible H9 cell line after 3 days of induction with 200 ng/ml doxycycline followed by 7 days of continued
culture after its withdrawal. Scale bars represent 100 mm.
(D) Real-time PCR analysis of the pluripotency marker OCT4 and the specific differentiation markers for mesodermal (Msx1), trophectodermal (Cdx2),
ectodermal (Pax6 and FGF5), and endodermal (GATA4, GATA6, AFP, albumin, and FoxA2) germ layers in the p21-inducible H9 cell line after the induction
conditions indicated. Data are shown as relative averages 6 SD of two biological replicates analyzed in triplicate.
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50lengthening presumably affects the G1 phase, given the fact
that both p15 and p16 are well-known cell-cycle inhibitors of
G1 CDKs [17–20]. Interestingly, it has been proposed that the
length of the G1 phase may influence the fate of stem cells
and is a determinant in stem cell differentiation [3,22–24].
We also demonstrated that induction of cell-cycle arrest
is sufficient to commit hES cells toward differentiation.Surprisingly, we were able to obtain differentiated cells when
culturing the cell-cycle-arrested cells in mTeSR1, a chemically
defined feeder-free hES cell medium [25]. We further observed
that the differentiation triggered by inducing cell-cycle arrest in
hES cells is an irreversible process. In fact, 3 days of cell-cycle
arrest was sufficient to commit hES cells toward differentia-
tion. These results suggest that hES cells are specified to
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51maintain a high proliferation rate in order to support their self-
renewal. In fact, whereas the expression of p15 or p16 in
somatic cells, such as keratinocytes, induced a complete
cell-cycle arrest, the expression of the same proteins in hES
cells still enabled proliferation to occur despite causing alter-
ations to the cell-cycle structure. Moreover, we observed
that the cell-cycle properties found in hES cells are acquired
early in the process of cell reprogramming. Overcoming the
cell-cycle arrest induced by OSKC expression might be an
early and necessary event for successful reprogramming
[16]. In fact, it has been reported that silencing of the Ink4/
Arf locus occurs early in cell reprogramming [26]. Moreover,
OCT4 is able to inhibit the expression of the p21 promoter
[6]. In agreement, as early as day 10 days after infection of
dFib-OCT4GFP cells, we detected highly proliferative small
colonies in which the endogenous pluripotent network was
already reactivated (Figure 1D).
Finally, we showed that stimulation of cell proliferation
improves somatic cell reprogramming, whereas the induction
of cell-cycle arrest impairs this process. Indeed, some of the
first genetic events during cell reprogramming are the inactiva-
tion of the p53/p21 pathway [27–29] and the Ink4/Arf locus [26].
Our results establish a perfect correlation between the
stimulation or the inhibition of cell proliferation and the effi-
ciency of cell reprogramming. Interestingly, we observed
that expression of different CDKs, such as CDK4 or CDK2,
neither modified the percentage of cells in S phase nor
impacted the reprogramming efficiency. Conversely, the
expression of their corresponding activators, CycD1/D2 or
CycE2 respectively, positively increased both processes.
This can be explained by the fact that cyclins are the limiting
factor in inducing CDK activity and promoting entry into S
phase. Consequently, coexpression of CycD1/CDK4 induced
a higher accumulation of cells in S phase and increased
reprogramming efficiency up to 10-fold. However, we did not
observe variation in the efficiency of reprogramming after the
coexpression of CycE/CDK2, which correlated with the
absence of a change in proliferation status in cells subjected
to reprogramming (data not shown). Nonetheless, the exact
mechanisms bywhich cell division affects reprogramming effi-
ciency are unknown. It is possible that active promotion of
transition through S phase might enable epigenetic resetting
of the genome and/or promote proliferation to increase the
number of cells available for stochastic reprogramming.
Overall, we have demonstrated that self-renewal and pluri-
potency rely on the particular cell-cycle regulation observed
in hES cells. Consequently, we show that a high proliferation
rate is a requirement for the acquisition and maintenance
of pluripotency and self-renewal of hES and hiPS cells. In
summary, we provide strong evidence showing that cell-cycle
regulatory pathways and the pluripotency network are intri-
cately connected to safeguard ES cell identity.
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